BioCentury
ARTICLE | Clinical News

Graspa regulatory update

September 21, 2015 7:00 AM UTC

Erytech submitted an MAA to EMA for Graspa to treat acute lymphoblastic leukemia (ALL). Graspa is L-asparaginase encapsulated in red blood cells. The Orphan Europe subsidiary of Recordati S.p.A. (Mil...